Skip Navigation
Search Menu
Find a Doctor


Photo of Dr. Maria Roselle Abraham, M.B.B.S., M.D.

Maria Roselle Abraham, M.B.B.S., M.D.

Co-Director, Hypertrophic Cardiomyopathy Center of Excellence
Assistant Professor of Medicine


Appointment Phone


Main Location

Johns Hopkins Outpatient Center

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Co-Director, Hypertrophic Cardiomyopathy Center of Excellence
  • Assistant Professor of Medicine

Centers & Institutes



Johns Hopkins Outpatient Center

Appointment Phone: 410-502-7974

601 N. Caroline Street
Baltimore, MD 21287 map
Phone: 410-502-2685


Arrhythmia, Cardiac Disease, Cardiac Electrophysiology, Cardiology , Cardiomyopathy, Cardiovascular Disease, Chest Pain, Clinical Cardiology, Congestive Heart Failure, Electrophysiology, Event Monitors, General Cardiology, Heart Attack, Heart Block, Heart Conditions, Heart Disease, Heart Failure, Holter Monitoring, Hypertrophic Cardiomyopathy, Inherited Arrhythmia Disorders, Inherited Heart Diseases, Irregular Heartbeat, Ischemic Heart Disease, Myocardial Infarction, Myocardial Perfusion Imaging, Palpitations, Paroxysmal Supraventricular Tachycardia, Stress Testing, Stress-induced Cardiomyopathy, Sudden Cardiac Death, Supraventricular Tachycardia, Tachycardias, Valvular Heart Disease

Research Interests

Use of stem cells to repair damaged hearts; Stem cell engineering


Dr. Roselle Abraham is co-director of the Hypertrophic Cardiomyopathy Center of Excellence in the Johns Hopkins Heart and Vascular Institute. She is also the center’s director of research. Dr. Roselle’s research ranges from diagnostic techniques and standards for cardiomyopathy to bioengineering stem cells to improve their effectiveness as therapy for cardiovascular disease, and she holds patents for stem cell applications.

Dr. Abraham graduated from Goa Medical College in India. She completed her internship in internal medicine at Wake Forest University in Winston-Salem, North Carolina and her residency in internal medicine at Parkland Hospital in Dallas, Texas. Dr. Abraham performed fellowships in cardiovascular diseases and in electrophysiology at the Mayo Clinic before joining Johns Hopkins University as a research associate in cardiovascular diseases. She joined the faculty of the Johns Hopkins School of Medicine in 2003 and also teaches bioengineering at Johns Hopkins University.

Dr. Abraham established the Hypertrophic Cardiomyopathy Basic and Translational Research Program at Johns Hopkins Medicine. She has published over 50 journal articles and book chapters, and has functioned as peer reviewer for over a dozen journals. more

    Additional Information

  • Education +


    • Goa Medical College / MD (1989)


    • Goa Medical College / Pediatrics (1991)
    • Goa Medical College / Internal Medicine (1994)
    • Wake Forest University Baptist Medical Center / Internal Medicine (1996)
    • University of Texas Southwestern Medical School / Internal Medicine (1998)


    • Mayo Clinic Medical School College of Medicine / Cardiovascular Disease (2002)
  • Research & Publications +

    Lab Website: Roselle Abraham Lab

    Selected Publications

    Recent Publications

    Rachel Ruckdeschel Smith; Lucio Barile; Hee Cheol Cho; Michelle K. Leppo; Joshua M. Hare; Elisa Messina; Alessandro Giacomello; M Roselle Abraham; Eduardo Marbán. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7):896-908.

    Circulation Research. 2005;97(2):159-167.

    Antonio J. Carrasco; Petras P. Dzeja; Alexey E. Alekseev; Darko Pucar; Leonid V. Zingman; M. Roselle Abraham; Denice Hodgson; Martin Bienengraeber; Michel Puceat; Edwin Janssen; et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(13):7623-7628.

    Zhou L, Solhjoo S, Millare B, Plank G, Abraham MR, Cortassa S, Trayanova N, O’Rourke B. Effects of regional mitochondrial depolarization on electrical propagation: implications for arrhythmogenesis. Circ Arrhythm Electrophysiol. 2014 Feb 1;7(1):143-51.

    Soleimanifard S, Abd-Elmoniem KZ, Sasano T, Agarwal HK, Abraham MR, Abraham TP, Prince JL. Three-dimensional regional strain analysis in porcine myocardial infarction: a 3T magnetic resonance tagging study. J Cardiovasc Magn Reson. 2012 Dec 13;14(1):85.

    Saha S, Corona-Villalobos C, Hurtado-de-Mendoza D, Noureldin R, Zimmerman SL, Bluemke DA, Kamel I, Abraham TP, Abraham MR. Higher Cornell product and QTc on exercise stress testing are correlated with lower T1 times by cardiac MRI in hypertrophic Cardiomyopathy. In review

    Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham MR, Wahl R, Bengel FM, Higuchi T. Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and Metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1077-83.

    Reid B, Afzal JM, McCartney AM, Abraham MR, O’Rourke B, Elisseeff JH. Enhanced tissue production through redox control in stem cell-laden hydrogels. Tissue Eng Part A. 2013 Sep;19(17-18):2014-23.

    Rahman QA, Tereshchenko LG, Kongkatong M, Abraham TP, Abraham MR, Shatkay H. Identifying hypertrophic cardiomyopathy patients by classifying individual heart beats from 12-lead ECG signals. In review.

    Reviews, Book Chapters and Editorials

    Wu JC, Abraham MR, Kraitchman D. Perspectives on imaging cardiac stem cell therapy. J of Nuclear Medicine, 2010 May 1:51 Suppl 1:128S-136S. Epub 2010 Apr 15

    Vakrou S, Abraham MR. Hypertrophic cardiomyopathy: a heart in need of an energy bar?Front Physiol. 2014 Aug 19;5:309

    Stastna M, Abraham MR, Van Eyk JE. Cardiac stem/progenitor cells, secreted proteins and proteomics. FEBS Lett. 2009, Jun 5;583(11):1800-7. Epub 2009 Mar 20.

    Chan A, Abraham MR. SPECT and PET to optimize cardiac stem cell therapy. J. Nucl Cardiol., 2012 Feb;19(1):118-25.

    Bonios M, Terrovitis J, Abraham MR. Stem cell: ‘Kant’ you see it? J. of Cardiovasc. Trans. Res. 2008, 1:103–105.

    Abraham MR, Jahangir A, Terzic A. Channelopathies of inwardly rectifying potassium channels. FASEB J 1999; 13: 1901-1910.

    Abraham MR, Hare JM. Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm, 2006, Apr;3(4):462-3.

    Abraham MR, Gerstenblith G. Preconditioning stem cells for cardiovascular disease: An important step forward. Circulation Research, 2007 Mar 2;100(4):447-9.


    Cardiac Stem Cells
    Patent # WO2006052925 A3 | 05/14/2009

    Human cardiac stem cells can be isolated from endomyocardial biopsies. Such cells mediate cardiac regeneration and improve heart function in a mouse infarct model. The cells can be used for autologous, allogeneic, syngeneic, or xenogeneic therapeutic applications in patients. The stem cells can be genetically modified to enhance their therapeutic activity.

    {line break}


    Preventing Arrhythmias Associated With Cell Transplantation
    Patent # WO2005092033 A3 | 09/27/2007

    Skeletal myoblasts are an attractive cell type for transplantation since they are autologous and resistant to ischemia. However, clinical trials of myoblasts transplantation in heart failure have been plagued by ventricular tachy-arrhythmias and sudden cardiac death. The pathogenesis of these arrhythmias is poorly understood, but may be related to the fact that skeletal muscle cells, unlike heart cells, are electrically isolated by the absence of gap junctions. An in vitro model of myoblasts transplantation into cardiomyocyte monolayers can be used to investigate the mechanisms of transplant-associated arrhythmias. Co-cultures of human skeletal myoblasts and rat cardiomyocytes result in reentrant arrhythmias (spiral waves) that reproduce the features of ventricular tachycardia seen in patients receiving myoblasts transplants. These arrhythmias can be terminated by nitrendipine, an L-type calcium channel Mocker, but not by the Na channel blocker lidocaine. Genetic modification of myoblasts to stably express the gap junction protein connexin 43 decreases arrhythmogenicity in co-cultures. It similarly can be used to increase the safety of myoblasts transplantation in patients.

    {line break}


  • Academic Affiliations & Courses +
  • Activities & Honors +


    • Guidant/NASPE Electrophysiology Research Award, 1998
    • Mayo Foundation Clinical Research Award, 1999
    • American College of Cardiology Career Development Award, 2002
    • Finalist, AHA Melvin Marcus Young Investigator Award, 2004
    • Johns Hopkins University Clinician Scientist Award, 2005


    • American College of Cardiology, 1999
    • American Heart Association, 1999
    • Council on Basic Cardiovascular Sciences, American Heart Association, 1999
    • Council on Clinical Cardiology, American Heart Association, 1999
    • Heart Rhythm society, 1999
  • Videos & Media +

    Lectures and Presentations

    Stem cell therapy: secrets to success
    Hellenic Heart Failure Society Meeting' , Greece (01/01/2011)

    Hypertrophic cardiomyopathy
    Institute of Genetic Medicine , Johns Hopkins Hospital (01/01/2011)

    SPECT and PET to Assess Cardiac Stem Cell Therapy
    ACC Scientific Sessions , New Orleans (01/01/2011)

    Promises and pitfalls of stem cell therapy for cardiac regeneration
    Cardiology Grand Rounds , Johns Hopkins Hospital (01/01/2010)

    Imaging of regenerative therapy
    Cardiac PET/CT and SPECT/CT course , Johns Hopkins Hospital (01/01/2010)

    Update on Genetics And Sudden Cardiac Death
    Keynote address-Women in Electrophysiology conference , Washington D.C. (01/01/2009)

    Cardiac-derived stem cell imaging using PET, SPECT
    Cardiovascular Molecular Imaging Conference , Bethesda

Is This You? Edit Profile